Phase 2 Ascites Clinical Trials

8 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 18 of 8 trials

Recruiting
Phase 1Phase 2

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

AscitesOvarian Neoplasms Malignant
Cancer Institute and Hospital, Chinese Academy of Medical Sciences29 enrolled1 locationNCT07435701
Recruiting
Phase 2

Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis

CirrhosisDecompensated Cirrhosis of LiverDecompensated Liver Cirrhosis+1 more
CAMC Health System50 enrolled1 locationNCT06764966
Recruiting
Phase 1Phase 2

Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites

Ascites, MalignantCancer of Stomach, Adenocarcinoma
Qilu Hospital of Shandong University24 enrolled1 locationNCT06759064
Recruiting
Phase 2

High Dose Albumin in Refractory Ascites

Ascites
Baylor College of Medicine100 enrolled1 locationNCT05867602
Recruiting
Phase 2

Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites

CirrhosisAscites Hepatic
Anahita Rabiee MD MHS20 enrolled1 locationNCT06812390
Recruiting
Phase 2

A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

Cirrhotic Ascites
Healthgen Biotechnology Corp.220 enrolled1 locationNCT04835480
Completed
Phase 2

Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites.

Diuretic refractory ascitesCirrhosisAscites+1 more
Paul Gow5 enrolled1 locationACTRN12616000321448
Completed
Phase 2

A Phase II study to evaluate the safety and potential palliative benefit of intraperitoneal bevacizumab in patients with symptomatic ascites due to advanced chemotherapy resistant gynaecological cancers: REZOLVE

AscitesAdvanced chemotherapy resistant gynaecological cancers
University of Sydney24 enrolled6 locationsACTRN12611000801910